摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

萘二异氰酸酯 | 25551-28-4

中文名称
萘二异氰酸酯
中文别名
——
英文名称
naphthylene diisocyanate
英文别名
1,2-naphthalene diisocyanate;napthylenediisocyanate;naphthalene diisocyanate;1,2-diisocyanatonaphthalene
萘二异氰酸酯化学式
CAS
25551-28-4
化学式
C12H6N2O2
mdl
——
分子量
210.192
InChiKey
ZXHZWRZAWJVPIC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    58.9
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME
    申请人:KABUSHIKI KAISHA SHOFU
    公开号:US20190300552A1
    公开(公告)日:2019-10-03
    The present invention relate to a novel silane coupling agent and a medical and/or dental curable composition comprising the same. It is an object of the present invention to provide a novel silane coupling agent that imparts high affinity to a radical polymerizable monomer, thereby imparting high mechanical strength, flexibility and durability when used for a medical and/or dental curable composition, and an inorganic filler surface-treated with the novel silane coupling agent and a novel medical and/or dental curable composition. A silane coupling agent including repeating units such as a urethane bond and polyethylene glycol (ether bond) at a specific position is used.
    本发明涉及一种新型硅烷偶联剂以及包括该偶联剂的医用和/或牙科可固化组合物。本发明的目的是提供一种新型硅烷偶联剂,使其对自由基聚合单体具有高亲和力,从而在用于医用和/或牙科可固化组合物时赋予高机械强度、柔韧性和耐久性,并且包括经新型硅烷偶联剂表面处理的无机填料和新型医用和/或牙科可固化组合物。该硅烷偶联剂包括在特定位置具有尿素键和聚乙二醇(醚键)等重复单元。
  • Process for the preparation of isocyanates in the gas phase
    申请人:Pohl Fritz
    公开号:US20080167490A1
    公开(公告)日:2008-07-10
    Isocyanates are produced by reaction of primary amines with phosgene in the gas phase. In this process, the reaction is terminated by guiding the reaction mixture from the reaction chamber through a cooling stretch into which liquids are injected. Direct cooling takes place in the cooling stretch in one stage in two or more cooling zones connected in series.
    异氰酸酯是通过初级胺与光气在气相中反应产生的。在这个过程中,通过将反应混合物从反应室引导到一个冷却拉伸段并在其中注入液体来终止反应。直接冷发生在连接的串联的两个或更多的冷却区域的冷却拉伸中的一个阶段。
  • Method For Producing Diisocyanates
    申请人:Wolfert Andreas
    公开号:US20080200722A1
    公开(公告)日:2008-08-21
    The present invention relates to a process for preparing diisocyanates from diamines and phosgene in the gas phase.
    本发明涉及一种从二胺和光气在气相中制备二异氰酸酯的方法。
  • Compounds containing quaternary carbons and silicon-containing groups, medical devices, and methods
    申请人:Medtronic, Inc.
    公开号:US20040054210A1
    公开(公告)日:2004-03-18
    Compounds that include diorgano groups having quaternary carbons, silicon-containing groups, and optionally urethane groups, urea groups, or combinations thereof (i.e., polyurethanes, polyureas, or polyurethane-ureas), as well as materials and methods for making such compounds.
    包括具有季铵碳、含硅基团和可选的脲基、尿素基或它们的组合(即聚氨酯、聚脲或聚氨酯脲)的二有机基团化合物,以及制备这些化合物的材料和方法。
  • 2-oxo-1,3-dioxolane-4-carboxamide building blocks, their preparation and use
    申请人:Construction Research & Technology GmbH
    公开号:EP2762471A1
    公开(公告)日:2014-08-06
    The present invention suggests a 2-oxo-1,3-dioxolane-4-carboxamide of formula (I), wherein R is an n-valent radical, n is an integer from 2 to 10 and x is an integer from 1 to n-1. The invention furthermore suggests a process for the preparation of the 2-oxo-1,3-dioxolane-4-carboxamide of formula (I) from 2-oxo-1,3-dioxolane-4-carboxylic acid of formula (II) with a polyisocyanate of the formula R(NCO)n, where R and n have the meanings given, and the use of the 2-oxo-1,3-dioxolane-4-carboxamide of formula (I) for the preparation of a 2-oxo-1,3-dioxolane-4-carboxamide-substituted prepolymer.
    本发明提出了一种式(I)的2-氧代-1,3-二氧杂环戊烷-4-羧酰胺, 其中R是一个n价基团,n是从2到10的整数,x是从1到n-1的整数。该发明进一步提出了一种从式(II)的2-氧代-1,3-二氧杂环戊烷-4-羧酸制备式(I)的2-氧代-1,3-二氧杂环戊烷-4-羧酰胺的方法 与式R(NCO)n的多异氰酸酯反应,其中R和n具有所述的含义,并且使用式(I)的2-氧代-1,3-二氧杂环戊烷-4-羧酰胺制备2-氧代-1,3-二氧杂环戊烷-4-羧酰胺取代预聚合物。
查看更多